Crossmark

Liver biopsy-proven non-alcoholic fatty liver disease predicts no impact on antiviral response in patients with chronic hepatitis B

Crossref DOI link: https://doi.org/10.1016/j.clinsp.2024.100493

Published Print: 2024-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Chen, Miao-Yang http://orcid.org/0000-0002-6597-6261
Li, Shun-Xin http://orcid.org/0009-0002-1789-1877
Du, Zhi-Xiang http://orcid.org/0000-0002-3597-5874
Xiong, Qing-Fang http://orcid.org/0000-0002-7758-5831
Zhong, Yan-Dan http://orcid.org/0000-0003-4580-9375
Liu, Du-Xian http://orcid.org/0009-0009-1466-9438
Yang, Yong-Feng http://orcid.org/0000-0002-3214-0038
License Information

Text and Data Mining valid from 2024-01-01

Text and Data Mining valid from 2024-01-01

Version of Record valid from 2024-08-29
More Information

This article is maintained by: Elsevier

Article Title: Liver biopsy-proven non-alcoholic fatty liver disease predicts no impact on antiviral response in patients with chronic hepatitis B

Journal Title: Clinics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.clinsp.2024.100493

Content Type: article

Copyright: © 2024 HCFMUSP. Published by Elsevier España, S.L.U.